Description de l'entreprise
Zealand Pharma A/S is a biotechnology company focused on the discovery and development of peptide-based medicines. More than 10 drug candidates invented by Zealand have advanced into clinical development, of which two have reached the market and three candidates are in late-stage development. The company has development partnerships with a number of pharma companies as well as commercial partnerships for its marketed products.
Conseil d'administration & Conseil de surveillance
| PDG |
| Adam Steensberg |
| Conseil d'administration |
| Henriette Wennicke, David Kendall, Ivan Møller, Christina Sonnenborg Bredal , Ravinder Chahil |
| Conseil de surveillance |
| Martin Nicklasson, Kirsten A. Drejer, Jeffrey Berkowitz, Bernadette Connaughton, Leonard Kruimer, Alain Munoz, Michael John Owen, Frederik Barfoed Beck, Anneline Nansen, Louise Gjelstrup, Jens Peter Stenvang, Enrique Conterno, Elaine Sullivan |
Données de l'entreprise
| Nom: |
Zealand Pharma A/S |
| Adresse: |
Sydmarken 11,2860 Søborg |
| Téléphone: |
- |
| Fax: |
- |
| Courriel: |
+45 88 77 36 00
|
| Internet: |
info@zealandpharma.com |
| Industrie: |
Biotechnology |
| Secteur: |
Biotechnology |
| Sous-secteur: |
- |
| Fin de l'exercice financier: |
31/12 |
| Flotte libre: |
- |
| IPO date: |
- |
Relations avec les investisseurs
| Nom: |
Anna Krassowska |
| Téléphone IR: |
- |
| IR-Fax: |
- |
| E-mail IR: |
ank@zealandpharma.com
|
